SCHEMBL107867

SCHEMBL107867

CCCCC(O)CCC(C)C

nearest known ligand 0.43

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.43
FFAR1 O14842 1/20 0.43
NFKB1 P19838 1/20 0.42
FDPS P14324 1/20 0.41
GPR84 Q9NQS5 5/20 0.41
CA1 P00915 2/20 0.38
SPHK1 Q9NYA1 1/20 0.38
FAAH O00519 2/20 0.38
ALDH1A1 P00352 1/20 0.37
DNM1 Q05193 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4057249 0.92 FFAR4 (0.52) FFAR4FFAR1NFKB1FDPSGPR84
SCHEMBL16744186 0.92 FFAR4 (0.52) FFAR4FFAR1NFKB1FDPSGPR84
SCHEMBL8897084 0.90 FFAR1 (0.55) FFAR4FFAR1NFKB1FDPSGPR84
SCHEMBL28277114 0.90 FFAR1 (0.55) FFAR4FFAR1NFKB1FDPSGPR84
SCHEMBL8388624 0.90 FFAR1 (0.55) FFAR4FFAR1NFKB1FDPSGPR84
SCHEMBL17526403 0.90 LMNA (0.43) FFAR4FFAR1NFKB1FDPSGPR84
SCHEMBL17526455 0.90 FFAR4 (0.48) FFAR4FFAR1NFKB1FDPSGPR84
SCHEMBL31038971 0.90 FFAR4 (0.48) FFAR4FFAR1NFKB1FDPSGPR84
SCHEMBL17526442 0.90 LMNA (0.43) FFAR4FFAR1NFKB1FDPSGPR84
SCHEMBL7404028 0.90 LMNA (0.43) FFAR4FFAR1NFKB1FDPSGPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2463374-A2 Isolated alcohol dehydrogenase enzymes and uses thereof Bio Architecture Lab, Inc. (US) 2012-06-13 EP claimed
EP-2195440-A2 BIOFUEL PRODUCTION Bio Architecture Lab, Inc. (US) 2010-06-16 EP claimed
US-20090155873-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-18 US claimed
US-20090139134-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-04 US claimed
WO-2009046375-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
WO-2009046370-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO claimed
US-12624164-B2 Synthetic thickeners incorporating non-reactive diluents HERCULES LLC (US) 2026-05-12 US disclosed
US-12590181-B2 Hydrophobically-modified associative thickener polymers process for the preparation and uses thereof HERCULES LLC (US) 2026-03-31 US disclosed
EP-4192923-B1 HYDROPHOBICALLY-MODIFIED ASSOCIATIVE THICKENER POLYMERS PROCESS FOR THE PREPARATION AND USES THEREOF HERCULES LLC (US) 2025-10-29 EP disclosed
EP-3230463-B2 RAPID PRETREATMENT APALTA PATENTS OUE (EE) 2025-07-16 EP disclosed
CN-116324123-B Hydrophobically modified associative thickener polymer and preparation method and application thereof 赫尔克里士有限公司 2025-03-18 CN disclosed
CN-116324124-B Hydrophobically modified associative thickener polymer and preparation method and application thereof 赫尔克里士有限公司 2025-03-18 CN disclosed
US-20250000088-A1 ANT CONTROL AGENT AND ANT CONTROL METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-01-02 US disclosed
US-20100086981-A1 COMPOSITIONS AND METHODS FOR IMPROVED SACCHARIFICATION OF BIOMASS QTEROS, INC. (US) 2010-04-08 US disclosed
US-20090203089-A1 ISOLATED ALCOHOL DEHYDROGENASE ENZYMES AND USES THEREOF BIO ARCHITECTURE LAB, INC. (US) 2009-08-13 US disclosed
WO-2009097346-A2 ISOLATED ALCOHOL DEHYDROGENASE ENZYMES AND USES THEREOF BIO ARCHITECTURE LAB, INC. (US) 2009-08-06 WO disclosed
US-20090155873-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-18 US disclosed
US-20090139134-A1 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-06-04 US disclosed
WO-2009046375-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO disclosed
WO-2009046370-A2 BIOFUEL PRODUCTION BIO ARCHITECTURE LAB, INC. (US) 2009-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624164-B2 Synthetic thickeners incorporating non-reactive diluents GEMIN4, MAGT1, SETDB1 FFAR4 2070/4885FFAR1 2809/4885NFKB1 4523/4885
US-12590181-B2 Hydrophobically-modified associative thickener polymers process for the preparation and uses thereof PHOSPHO1, H1-10, H1-0 FFAR4 2715/4885FFAR1 2769/4885NFKB1 3859/4885
US-20090139134-A1 BIOFUEL PRODUCTION MGAM, DCXR, MANBA FFAR4 1011/4885FFAR1 1107/4885NFKB1 4175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.